Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Biomedicines
|
March 28, 2025
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alexandre Serra-Llovich, Natalia Cullell, Olalla Maroñas, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2020
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
Miquel Pujol, José-María Miró, Evelyn Shaw, et al.
BMJ Open
|
August 6, 2021
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia: study protocol for the SAFO trial
Sara Grillo, Guillermo Cuervo, Jordi Carratala, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Biomedicines
|
March 28, 2025
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alexandre Serra-Llovich, Natalia Cullell, Olalla Maroñas, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2020
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
Miquel Pujol, José-María Miró, Evelyn Shaw, et al.
BMJ Open
|
August 6, 2021
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia: study protocol for the SAFO trial
Sara Grillo, Guillermo Cuervo, Jordi Carratala, et al.
Page
of 8